These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5449568)

  • 41. [Basophilic serological test in side effects of antituberculous drugs of the first series].
    Shmelev NA; Koviazina AI
    Probl Tuberk; 1969; 47(5):38-43. PubMed ID: 5367969
    [No Abstract]   [Full Text] [Related]  

  • 42. [Sideroblastic anemia after treatment with isoniazid (Nidrazid)].
    Chrobák L
    Vnitr Lek; 1974 Jul; 20(6):563-6. PubMed ID: 4844790
    [No Abstract]   [Full Text] [Related]  

  • 43. [Anaphylactic shock caused by Fintozid].
    Földeş I; Norbert G
    Ftiziologia; 1971; 20(4):429-31. PubMed ID: 5162280
    [No Abstract]   [Full Text] [Related]  

  • 44. [The algodystrophies caused by antituberculous chemotherapy. Study of 24 cases].
    Renier JC; Oury M; Bregeon C; Tuchais E
    Rev Rhum Mal Osteoartic; 1969 Nov; 36(11):605-7. PubMed ID: 5367163
    [No Abstract]   [Full Text] [Related]  

  • 45. [Disorders of carbohydrate metabolism after administration of isoniazid, streptomycin and PAS and their correction with thiamine and nicotinic acid].
    Chirkin AA; Romanovskiĭ RV; Solov'ev IuA
    Probl Tuberk; 1986; (5):61-4. PubMed ID: 3737600
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 47. [Results of treatment of pulmonary tuberculosis under conditions of compulsory isolation].
    Zaworski C
    Gruzlica; 1967 May; 35(5):441-5. PubMed ID: 6056258
    [No Abstract]   [Full Text] [Related]  

  • 48. A follow-up study of 134 cases of pulmonary tuberculosis treated with adequate chemotherapy in 1953-1954.
    Cheung OT; Pugsley HE
    Can Med Assoc J; 1968 Jun; 98(25):1182-3. PubMed ID: 5657185
    [No Abstract]   [Full Text] [Related]  

  • 49. [Distant repercussions on the cardiovascular apparatus of tuberculous processes cured with specific antibacterial therapy alone].
    Mistretta A
    Lotta Tuberc; 1971; 41(4):629-33. PubMed ID: 5291688
    [No Abstract]   [Full Text] [Related]  

  • 50. [Changes in the cardiovascular system of patients with hematogenous-disseminated tuberculosis of the lung].
    Evdokimova AD; Lachinian SR; Kidanova ZS
    Probl Tuberk; 1966; 44(2):40-7. PubMed ID: 5984586
    [No Abstract]   [Full Text] [Related]  

  • 51. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 52. [Toxico-allergic reactions in the use of antibacterial preparations in patients with tuberculosis of the lungs].
    Shapiro BIa
    Sov Med; 1965 Oct; 28(10):90-2. PubMed ID: 5895951
    [No Abstract]   [Full Text] [Related]  

  • 53. Case of extreme hypersensitivity to almost all antituberculous drugs.
    Agrawal R
    Br Med J; 1969 Nov; 4(5682):540. PubMed ID: 5354853
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effectiveness of chemotherapy in patients with primary distructive tuberculosis].
    Novikova NA
    Probl Tuberk; 1967; 45(5):21-6. PubMed ID: 5617940
    [No Abstract]   [Full Text] [Related]  

  • 55. [Side-effects in chemotherapy of pulmonary tuberculosis].
    Savula MM; Smachilo DT; Kiselova ES
    Probl Tuberk; 1976 Feb; (21):39-43. PubMed ID: 1264981
    [No Abstract]   [Full Text] [Related]  

  • 56. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 57. The management of hypersensitivity reactions to antituberculosis drugs.
    Thompson JE
    Med J Aust; 1969 Nov; 2(21):1058-63. PubMed ID: 5373732
    [No Abstract]   [Full Text] [Related]  

  • 58. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 59. [The pseudorheumatism of antitubercular chemotherapy. Contribution to the study of the etiopathogenesis of neurotrophic rheumatism].
    Marche J; Chatard P
    Rev Rhum Mal Osteoartic; 1967; 34(1):16-33. PubMed ID: 4169554
    [No Abstract]   [Full Text] [Related]  

  • 60. [Modification in standard chemotherapy: administration of drugs in a single daily dose (Preliminary report)].
    Bukalska Z; Rózewska M; Gajewska E
    Gruzlica; 1968 Oct; 36(11):1161-6. PubMed ID: 5710705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.